Message from the Director Dear Friends of UCI MIND, Happy New Year! We hope that 2024 is off to a positive start for you. As we embark upon a new…
Read More
Message from the Director Dear Friends of UCI MIND, Advances in the field of Alzheimer’s disease (AD) research and the contributions of UCI MIND investigators remain tremendously exciting. Two new…
Read More
Message from the Director Dear Friends of UCI MIND, As the fall MIND Matters newsletter goes to print, many of us are preparing to travel to San Francisco for the…
Read More
Message from the Director Dear Friends of UCI MIND, We hope that you had a summer full of sun, fun, and good health. As you can see in this issue…
Read More
When Weil was in her 90s, she enrolled in the 90+ Study, a UC Irvine program initiated in 2003 to study “the oldest-old.” The program started in 1981 as the…
Read More
Contributed by Joshua Grill, PhD Since Wednesday’s announcement by Eisai and Biogen of positive topline Phase 3 results for their treatment lecanemab in early Alzheimer’s disease, the field has been…
Read More
Message from the Director Dear Friends of UCI MIND, Welcome to the new normal. COVID case numbers have surged again, but our research continues to push forward and our researchers…
Read More
Message from the Director Dear Friends of UCI MIND, The COVID-19 surge caused by the Omicron variant has produced unwanted challenges for our research. Yet, our investigators remain unrelenting and…
Read More
Contributed by Christian Salazar, PhD Black Americans are more likely than White Americans to be afflicted with Alzheimer’s disease. This may be of no surprise considering that some of the…
Read More
🎇Happy New Year from all of us at UCI MIND! The post Happy New Year from all of us at UCI MIND! appeared first on UCI MIND.
Read More